[1]
“A comparative study of efficacy and safety of topical travoprost 0.004% versus latanoprost 0.005% in the treatment of primary open angle glaucoma at a tertiary care hospital”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 6, no. 2, pp. 199–207, Apr. 2021, doi: 10.61096/ijrpp.v6.iss2.2017.199-207.